An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Research Publications (Food Safety)

This page tracks research articles published in national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. Research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies (requires login) and FDA Grant Funding Agencies (requires login) are also tracked in Scopus.

Displaying 451 - 475 of 704

  1. Estimation of COVID-19 burden in Egypt – Authors' reply

    • The Lancet Infectious Diseases
    • We thank Mohamed Hassany and colleagues, Ahmed Negida, Tarek Sahmoud, and Khaled Elmeleegy for raising their concerns about our modelling study. We would like to reiterate that the number of confirmed cases of coronavirus disease 2019 (COVID-19) in every country worldwide (Egypt included) is an underestimate of the true burden of illness, regardless of the screening programmes in place.

      • COVID-19
  2. Estimation of COVID-19 burden in Egypt

    • The Lancet Infectious Diseases
    • To estimate the burden of coronavirus disease 2019 (COVID-19) in Egypt, Ashleigh R Tuite and colleagues1 used the same model of exported case detection used by Fraser and colleagues for the H1N1 outbreak in Mexico.2 However, Tuite and colleagues neither clarified nor verified the assumptions of this exported case-detection model.

      • Viruses
      • COVID-19
      • COVID-19
      • COVID-19
      • COVID-19
  3. Estimation of the COVID-19 burden in Egypt through exported case detection

    • The Lancet Infectious Diseases
    • In December, coronavirus disease 2019 (COVID-19) emerged in Wuhan, China, causing a pandemic that continues to spread globally.1 86 countries have reported cases.2 As of March 6, 2020, Egypt has reported three cases of COVID-19; however, at least 14 cases have been exported from Egypt to four countries.3 The burden of infection in Egypt, therefore, might be substantially larger than reported.

      • COVID-19
  4. Exaggerated risk of transmission of COVID-19 by fomites

    • The Lancet Infectious Diseases
    • A clinically significant risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission by fomites (inanimate surfaces or objects) has been assumed on the basis of studies that have little resemblance to real-life scenarios.

      • COVID-19
  5. The COVID-19 infodemic

    • The Lancet Infectious Diseases
    • “We're not just fighting a pandemic; we're fighting an infodemic,” said Tedros Adhanom Ghebreyesus, WHO's director-general, at the 2020 Munich Security Conference. Fake news, misinformation, and conspiracy theories have become prevalent in the age of social media and have skyrocketed since the beginning of the COVID-19 pandemic. This situation is extremely concerning because it undermines trust in health institutions and programmes.

      • COVID-19
  6. Impact of contact tracing on SARS-CoV-2 transmission

    • The Lancet Infectious Diseases
    • As the far-reaching impacts of the coronavirus disease 2019 (COVID-19) pandemic expand to more and more countries, key questions about transmission dynamics and optimal intervention strategies remain unanswered. In particular, the age profile of susceptibility and infectivity, the frequency of super-spreading events, the amount of transmission in the household, and the contribution of asymptomatic individuals to transmission remain debated.

      • COVID-19
  7. Importance of precise data on SARS-CoV-2 transmission dynamics control

    • The Lancet Infectious Diseases
    • In December, 2019, COVID-19 was recognised as a novel respiratory disease in Wuhan, China,1 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).2 Accurate and reliable data on SARS-CoV-2 incubation time, secondary attack rate, and transmission dynamics are key to successful containment. In late January, 2020, infection with SARS-CoV-2 was detected in Germany for the first time.

      • COVID-19
  8. Opinion: Here’s how we restore productivity and vigor to the biomedical research workforce in the midst of COVID-19

    • Proceedings of the National Academy of Sciences
    • The first known case of the novel coronavirus (COVID-19) was reported in China in November 2019; in the United States, the first reported case was on January 22.* Essential stay-at-home mandates worldwide have helped mitigate the exponential growth in hospitalizations and death and have led to gradual reopenings in China,...

      • COVID-19
  9. Interdependence and the cost of uncoordinated responses to COVID-19

    • Proceedings of the National Academy of Sciences
    • Social distancing is the core policy response to coronavirus disease 2019 (COVID-19). But, as federal, state and local governments begin opening businesses and relaxing shelter-in-place orders worldwide, we lack quantitative evidence on how policies in one region affect mobility and social distancing in other regions and the consequences of uncoordinated...

      • COVID-19
  10. Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak

    • Proceedings of the National Academy of Sciences
    • The Diamond Princess cruise ship was put under quarantine offshore Yokohama, Japan, after a passenger who disembarked in Hong Kong was confirmed as a coronavirus disease 2019 case. We performed whole-genome sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly from PCR+ clinical specimens and conducted a phylogenetic analysis...

      • COVID-19
  11. Social distancing responses to COVID-19 emergency declarations strongly differentiated by income

    • Proceedings of the National Academy of Sciences
    • In the absence of a vaccine, social distancing measures are one of the primary tools to reduce the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, which causes coronavirus disease 2019 (COVID-19). We show that social distancing following US state-level emergency declarations substantially varies by income. Using...

      • COVID-19
  12. Timing social distancing to avert unmanageable COVID-19 hospital surges

    • Proceedings of the National Academy of Sciences
    • Following the April 16, 2020 release of the Opening Up America Again guidelines for relaxing coronavirus disease 2019 (COVID-19) social distancing policies, local leaders are concerned about future pandemic waves and lack robust strategies for tracking and suppressing transmission. Here, we present a strategy for triggering short-term shelter-in-place orders when...

      • COVID-19
  13. Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19

    • Journal of Clinical Pathology
    • Novel coronavirus (COVID-19) pneumonia has emerged as major global health threat as it continues to spread with increasing number of deaths. COVID-19 is an enveloped, single-stranded RNA coronavirus that is largely transmitted by inhalation of respiratory droplets.

      • COVID-19
  14. Focus on a 2019-novel coronavirus (SARS-CoV-2)

    • Future Microbiology
      • COVID-19
  15. N-acetylcysteine as a potential treatment for novel coronavirus disease 2019

    • Future Microbiology
      • COVID-19
  16. The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review

    • Future Microbiology
      • COVID-19
  17. COVID-19: in the absence of vaccination – ‘mask-the-nation’

    • Future Microbiology
      • COVID-19
  18. Anal swab as the potentially optimal specimen for SARS-CoV-2 detection to evaluate the hospital discharge of COVID-19 patients

    • Future Microbiology
      • COVID-19
  19. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease

    • Emerging Infectious Diseases
    • K. Chan et al.

      • COVID-19
  20. Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul

    • Emerging Infectious Diseases
    • M. Han et al.

      • COVID-19
  21. Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020

    • Emerging Infectious Diseases
    • S. Ryu et al.

      • COVID-19
  22. Community Treatment Centers for Isolation of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease, South Korea

    • Emerging Infectious Diseases
    • W. Choi et al.

      • COVID-19
  23. Clinical Course of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease Admitted to Community Treatment Centers, South Korea

    • Emerging Infectious Diseases
    • Y. Lee et al.

      • COVID-19
  24. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients

    • Emerging Infectious Diseases
    • P. Choe et al.

      • COVID-19
  25. Operating Protocols of a Community Treatment Center for Isolation of Patients with Coronavirus Disease, South Korea

    • Emerging Infectious Diseases
    • E. Kang et al.

      • COVID-19